去年，Haemonetics Corp表现最佳的业务板块Plasma products and services实现营收563.73M美元。United States的营收贡献最高，去年达到1.01B美元。最近一个季度，截至2023-04-01，Haemonetics Corp表现最佳的业务板块Plasma products and services实现营收148.32M美元。United States的营收贡献最高，达到257.84M美元。

业务

营业收入

占比

年报

年报

单季报

Plasma products and services

HospitalHospital products and services

Blood Center products and services

FY2023

FY2022

FY2021

FY2020

FY2019

Plasma products and services

563.73M(48.24%)

427.61M(43.05%)

414.27M(47.59%)

537.23M(54.35%)

501.84M(51.87%)

HospitalHospital products and services

378.11M(32.35%)

329.43M(33.17%)

216.58M(24.88%)

198.42M(20.07%)

196.54M(20.31%)

Blood Center products and services

226.82M(19.41%)

236.16M(23.78%)

239.61M(27.53%)

252.83M(25.58%)

269.20M(27.82%)

地区

营业收入

占比

年报

年报

单季报

United States

Europe

Asia

Japan

other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

1.01B(74.29%)

970.01M(74.10%)

842.90M(72.13%)

639.32M(64.37%)

522.61M(60.04%)

646.20M(65.37%)

606.85M(62.72%)

Europe

175.66M(12.91%)

160.14M(12.23%)

156.68M(13.41%)

163.52M(16.46%)

159.08M(18.27%)

153.35M(15.51%)

164.50M(17.00%)

Asia

92.31M(6.78%)

107.54M(8.21%)

104.14M(8.91%)

110.80M(11.16%)

105.82M(12.16%)

109.30M(11.06%)

118.70M(12.27%)

Japan

62.41M(4.59%)

58.09M(4.44%)

61.30M(5.24%)

75.56M(7.61%)

77.68M(8.92%)

72.22M(7.31%)

69.91M(7.23%)

other

19.54M(1.44%)

13.28M(1.01%)

3.65M(0.31%)

3.99M(0.40%)

5.28M(0.61%)

7.42M(0.75%)

7.62M(0.79%)